Last reviewed · How we verify

NCT07130279: PIR-TMD

Post-Isometric Relaxation in Temporomandibular Disorders

Not yet recruiting NA Last updated 19 August 2025
What this trial tests

NA trial testing Postural Exercises + Post-Isometric Relaxation (PIR) Technique in Temporomandibular Joint Disorders in 40 participants. Not yet recruiting.

Timeline
11 August 2025
Primary endpoint
22 September 2025
25 September 2025

Quick facts

Lead sponsorSanem ŞENER
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment40
Start date11 August 2025
Primary completion22 September 2025
Estimated completion25 September 2025

Drugs / interventions tested

Conditions studied

Sponsor

Sanem ŞENER

Who can join

Adults 18 to 25, any sex, with Temporomandibular Joint Disorders or Myofascial Pain Syndromes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This planned randomized, single-blind clinical trial will investigate the effects of adding the Post-Isometric Relaxation (PIR) technique to a standard postural exercise program in individuals with moderate to severe temporomandibular joint dysfunction (TMD). Forty volunteers aged 18-25 years will be recruited and randomly assigned to either an experimental group (postural exercises + PIR) or a control group (postural exercises only). The intervention will be delivered three times per week for six weeks. Primary outcomes will include cervical range of motion, mandibular mobility, head anterior tilt, and thoracic kyphosis index, measured before and after the intervention. The study aims to determine whether PIR provides additional benefits to standard postural exercises in improving jaw and neck function and postural alignment in young adults with TMD.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Temporomandibular Joint Disorders

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07130279.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing